Variant report
Variant | nsv962044 |
---|---|
Chromosome Location | chr2:187950103-187964615 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs5837014 | chr2:187957209-187957210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369293289 | chr2:187957211-187957212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs202146525 | chr2:187957212-187957213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368088418 | chr2:187957213-187957214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201201264 | chr2:187957215-187957216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs13024632 | chr2:187957266-187957267 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs536392628 | chr2:187957316-187957317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373997429 | chr2:187957349-187957350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573949642 | chr2:187957364-187957365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554532221 | chr2:187957368-187957369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569577060 | chr2:187957380-187957381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573246744 | chr2:187959642-187959643 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181058263 | chr2:187959664-187959665 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113076676 | chr2:187959763-187959764 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553263431 | chr2:187959823-187959824 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574680097 | chr2:187959851-187959852 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541657496 | chr2:187959857-187959858 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563541101 | chr2:187959873-187959874 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149123599 | chr2:187959874-187959875 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182947194 | chr2:187959905-187959906 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs71432484 | chr2:187959914-187959915 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376711646 | chr2:187959943-187959944 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113489043 | chr2:187959961-187959962 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs16828613 | chr2:187959963-187959964 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Bipolar disorder | 19114987 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:187957200-187957400 | Enhancers | Fetal Lung | lung |
2 | chr2:187959600-187960000 | Active TSS | HUVEC | blood vessel |